TRAVERSA SERGIO
Chief Executive Officer
DirectorOfficer
Latest Insider Transactions
5 transactions (past 365 days)
| 2026-09-11 | 2026-09-10 | RLMD Relmada Therapeutics, Inc. | CEO | Purchase | 100,000 | $4.10 | $410,000 |
| 2026-09-11 | 2026-09-09 | RLMD Relmada Therapeutics, Inc. | CEO | Purchase | 100,000 | $4.18 | $418,000 |
| 2025-12-16 | 2025-12-15 | RLMD Relmada Therapeutics, Inc. | CEO | Purchase | 27,500 | $4.12 | $113,300 |
| 2025-12-16 | 2025-12-12 | RLMD Relmada Therapeutics, Inc. | CEO | Award | 1,198,000 | $0.00 | $0 |
| 2025-11-06 | 2025-11-05 | RLMD Relmada Therapeutics, Inc. | CEO | Purchase | 272,500 | $2.20 | $599,500 |
RLMD
CEO
Purchase
$410K
100,000 shares @ $4.10
Filed 2026-09-11Trade 2026-09-10
Relmada Therapeutics, Inc.RLMD
CEO
Purchase
$418K
100,000 shares @ $4.18
Filed 2026-09-11Trade 2026-09-09
Relmada Therapeutics, Inc.RLMD
CEO
Purchase
$113.3K
27,500 shares @ $4.12
Filed 2025-12-16Trade 2025-12-15
Relmada Therapeutics, Inc.RLMD
CEO
Purchase
$599.5K
272,500 shares @ $2.20
Filed 2025-11-06Trade 2025-11-05
Relmada Therapeutics, Inc.